Protagonist Therapeutics
PTGX
PTGX
61 hedge funds and large institutions have $165M invested in Protagonist Therapeutics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
23% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 26
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Holders
61
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$13.7M | |
| 2 | +$12.3M | |
| 3 | +$8.29M | |
| 4 |
Jennison Associates
New York
|
+$3.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.85M |
Top Sellers
| 1 | -$5.05M | |
| 2 | -$3.36M | |
| 3 | -$2.57M | |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$1.74M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$984K |